Role of textural analysis of pretreatment 18F FDG PET/CT in response prediction in oesophageal carcinoma patients
Creators
- 1. Departments of 1Nuclear Medicine and Medical Oncology, AIIMS, Raipur, Chhattisgarh (India)
Description
PET/CT is routinely used for staging, response assessment and surveillance in oesophageal carcinoma patients. The aim of this study was to investigate whether textural features of pre-treatment 18F-FDG PET/CT images can contribute to prognosis prediction in carcinoma oesophagus patients. This is a retrospective study of 30 diagnosed carcinoma oesophagus patients. These patients underwent pre-treatment 18F-FDG PET/CT for staging. The images were processed in a commercially available textural analysis software. ROI was drawn over primary tumor with a 40% threshold and was processed further to derive 42 textural and radiomic parameters. These parameters were then compared between progression group and non-progression group. ROC curves were used to identify cut- off values for textural features with a p value <0.05 for statistical significance. A retrospective study of 30 primary carcinoma oesophagus patients was done. Patients were followed up after chemo-radiotherapy and they underwent follow up PET/ CT. On the basis of their response, patients were divided into progression group and non-progression group. Among them, 15 patients showed disease progression and 15 patients were in non- progression group. 10 textural analysis parameters turned out to be significant in prediction of disease progression. Cut off values were calculated for these parameters according to the ROC curves.
Additional details
Publishing Information
- Journal Title
- Indian Journal of Nuclear Medicine
- Journal Volume
- 37
- Journal Issue
- 5,suppl.1
- Journal Page Range
- p. S36-S37
- ISSN
- 0972-3919
INIS
- Country of Publication
- India
- Country of Input or Organization
- India
- INIS RN
- 54033855
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; ESOPHAGUS; FLUORINE 18; FLUORODEOXYGLUCOSE; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS
- Descriptors DEC
- ANTIMETABOLITES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MATERIALS; NANOSECONDS LIVING RADIOISOTOPES; NEOPLASMS; NUCLEI; ODD-ODD NUCLEI; ORGANS; RADIOACTIVE MATERIALS; RADIOISOTOPES; TOMOGRAPHY